Ordinary Index Rebalancing in the Medical Care Growth Index | November 2021

In the ordinary rebalance the following composition will be implemented effective open 04.11.2021:

ADVERUM BIOTECHNOLOGIES INC
ALECTOR INC
ANTARES PHARMA INC
ARCUS BIOSCIENCES INC
ATHERSYS INC
AVID BIOSERVICES INC
AXONICS INC
AYTU BIOPHARMA INC
BIOCEPT INC
BIOCRYST PHARMACEUTICALS INC
BIODELIVERY SCIENCES INTERNATIONAL INC
BIOHAVEN PHARMACEUTICAL HOLD
CO-DIAGNOSTICS INC
DECIPHERA PHARMACEUTICALS INC
DENALI THERAPEUTICS INC
DENTSPLY SIRONA INC
DYNAVAX TECHNOLOGIES CORP
EAGLE PHARMACEUTICALS INC/DE
ENVISTA HOLDINGS CORP
ETON PHARMACEUTICALS INC
FATE THERAPEUTICS INC
FULCRUM THERAPEUTICS INC
FULGENT GENETICS INC
G1 THERAPEUTICS INC
GLOBAL BLOOD THERAPEUTICS IN
GRITSTONE BIO INC
HALOZYME THERAPEUTICS INC
HARMONY BIOSCIENCES HOLDINGS INC
HESKA CORP
HOMOLOGY MEDICINES INC
IMMUNITYBIO INC
INARI MEDICAL INC
INOVIO PHARMACEUTICALS INC
INTRA-CELLULAR THERAPIES INC
JOINT CORP/THE
LA JOLLA PHARMACEUTICAL CO
LIGAND PHARMACEUTICALS INC
MATINAS BIOPHARMA HLDGS INC
MEI PHARMA INC
MERIDIAN BIOSCIENCE INC
MESA LABORATORIES INC
MIRATI THERAPEUTICS INC
MODERNA INC
NATUS MEDICAL INC
OCULAR THERAPEUTIX INC
ONCOCYTE CORP
ORGANOGENESIS HOLDINGS INC
PARATEK PHARMACEUTICALS INC
PHASEBIO PHARMACEUTICALS INC
PROTAGONIST THERAPEUTICS INC
REPLIGEN CORP
RESHAPE LIFESCIENCES INC
REVANCE THERAPEUTICS INC
SAGE THERAPEUTICS INC
SCYNEXIS INC
SELECTA BIOSCIENCES INC
SHOCKWAVE MEDICAL INC
STAAR SURGICAL CO
SYROS PHARMACEUTICALS INC
TACTILE SYSTEMS TECHNOLOGY INC
TANDEM DIABETES CARE INC
UROGEN PHARMA LTD
VACCINEX INC
VERICEL CORP
VIR BIOTECHNOLOGY INC
XENETIC BIOSCIENCES INC
XERIS BIOPHARMA HOLDINGS INC
ZOGENIX INC
ZYNEX INC